Meet our Board of Directors
PathoQuest is led by a board of directors who are seasoned leaders in their respective fields of business. Together, the members of the board of directors help to develop policies and strategies which are implemented by PathoQuest’s executive team.
Benedikt von Braunmühl - Chairman

Mr. Benedikt Von Braunmühl serves as CEO of the Synevo Division at Medicover. Mr. Von Braunmühl has held several high-profile healthcare consulting and advisory roles for companies across the globe supporting geographic expansion, business development, and mergers and acquisitions projects. Mr. Von Braunmühl previously was Senior Vice President – Global Commercial Operations of Qiagen NV, a leading European biotechnology company active in molecular diagnostics and life science markets. Mr. Von Braunmühl started his 25-year healthcare career at AstaMedica and has held various marketing and sales positions in the healthcare industry as well as in investment banking. Mr. Von Braunmühl holds a Bachelor Degree in Business Administration from the Graduate School of Business Administration in Zurich, Switzerland.

Jean-Pascal Beaufret
Mr. Jean-Pascal Beaufret is the Chief Financial Officer of NBN Co. Limited. Mr. Beaufret served as the Chief Financial Officer of Alcatel since 2002. He also served as a General Manager of Electrobanque. In 1999, Mr. Beaufret joined Alcatel as Deputy Chief Financial Officer of the Group. Mr. Beaufret served as an Executive in the Ministry of Finance (Treasury). As Deputy Secretary of the international department, he was responsible for export, credit negotiations and development aid from 1986 to 1988. As Deputy Secretary for monetary affairs, he was in charge of government debt management and financial industry regulation from 1988 to 1994. He served as Chief Financial Officer of Alcatel Optronics from January 1, 2002. From 1995 to 1997, Mr. Beaufret served as the Chief Financial Officer at Credit Foncier de France. He served as General Manager of the French tax administration office since 1997. Mr. Beaufret serves as Member of Advisory Board at Aurinvest. He has been Vice Chairman at Sequana S.A., since June 27, 2013 and has been its Independent Director since May 21, 2008. He served as Member of Supervisory Board at Portigon AG since August 1, 2002. Mr. Beaufret is a graduate of HEC (Paris Business School) and of the ENA (French National School of Public Administration).
Bernard Courtieu, DVM, MBA
Dr. Bernard Courtieu is President and CEO of IntegraGen SA, a publicly traded French-based genomic services and molecular diagnostic company. Prior to joining IntegraGen, Dr. Courtieu achieved significant success in the role of Practice Leader and later as Vice President within Gemini Consulting’s Life Sciences Division in France. During his tenure with Gemini Consulting and Cap Gemini Ernst and Young he yielded hands on experience in improving the operational performance of pharmaceutical companies in the fields of research and development, industrial operations, supply, sales and marketing and information systems. Previous to this, Dr. Courtieu held the position of Country Manager, France at Ariba, the world leader in spend management. In this role, he assisted companies in analyzing and managing their corporate spending in order to achieve increased business proficiency. Dr. Courtieu holds an MBA from the Instituto De Las Estudios Superiores De La Empresa, in Barcelona, Spain. He recieved his doctorate in Veterinary Medicine from the Ecole Vétérinaire d’Alfort and University Paris Xll, France.
Thierry Laugel, PhD, MBA

Dr. Thierry Laugel, Ph.D. is a co-Founder and Managing Partner at Kurma Partners since 2009. He was previously Partner at AGF Private Equity, (2006 to 2009) and CDC Innovation (1998 to 2005). Before that, he worked for Flamel Technologies as Project Director for Pharmaceutical R&D (1997-1998) and Fournier Japan, as Coordinator of R&D programmes (1992 – 1996). He has served as Director or Board member in more than 20 companies. Dr. Laugel holds a Pharm.D, a Ph.D. in Pharmacology, and an M.B.A. from INSEAD.